Press Releases News Events Publications Backed by broad syndicate, Mediar takes downstream approach to fibrosis With focus on fibrosis, startup Mediar draws big pharma backing Novartis and Pfizer-Backed Mediar Nets $85M for Fibrosis Paradigm Shift $105M raised: Mediar wins big pharma backing for novel fibrosis therapies Big Pharma companies back new startup out of Mass General Brigham MGB-backed biotech raises $85m to develop drugs for diseases that cause scarring in organs Five pharmas back $85M Series A for Mediar’s fibrosis-modulating antibodies Armed with $105M and Big Pharma backing, Mediar takes aim at fibrotic mediators Mediar Therapeutics Raises $105M in Funding Mediar Therapeutics boosts fibrosis portfolio with $105M financing Mediar Therapeutics Raises $105 Million Financing Mediar raises $105 million to target fibrotic mediators Big Pharma, VCs Bet $105M on Mediar’s Antibodies for Fibrotic Diseases
